Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
01. September 2021 16:15 ET
|
Codex
San Diego, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of its first full-length...
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
10. März 2021 10:00 ET
|
Codex
San Diego, March 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The...